This year's newsworthy drugs made strides against cancer, heart disease and more. Some drugs made headlines for their inability to succeed in clinical trials, and others are still waiting, stuck in limbo, for a chance to move forward in the pipeline. Here is a look at a few of them.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
06 January 2016
In the December 2015 issue, the piece "Drugs that made headlines in 2015" (Nat. Med. 21, 1382, 2015) did not specify that the different doses of aducanumab were compared with placebo, and that they were all conducted as part of the same study. The error has been corrected in the HTML and PDF versions of this article.
Rights and permissions
About this article
Cite this article
Chakradhar, S. Drugs that made headlines in 2015. Nat Med 21, 1382–1383 (2015). https://doi.org/10.1038/nm1215-1382
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1215-1382
This article is cited by
-
Corrections
Nature Medicine (2016)
